Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis. - GreenMedInfo Summary
Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats.
Expert Opin Drug Deliv. 2019 Dec 6:1-12. Epub 2019 Dec 6. PMID: 31782320
Noha S El-Salamouni
: Atopic dermatitis is a chronic inflammatory skin disease that remarkably affects the quality-of-life of patients. Chamomile oil is used to treat skin inflammations. We evaluated the efficacy of chamomile oil and nanoemulgel formulations as a natural alternative therapeutic option for atopic dermatitis.: Formulations were developed comprising chamomile oil: olive oil (1:1), Tween 20/80 or Gelucire 44/14 as surfactant-cosurfactant mixtures, propylene glycol (10%w/w), water and hydroxypropyl methylcellulose (3%w/w). In-vitro physicochemical characterization, stability testing and in-vivo assessment of inflammatory biomarkers and histopathological examination of skin lesions were conducted in rats induced with atopic dermatitis.: Nanoemulgels Gand Xwhich displayed the smallest particle size of 137.5 ± 2.04 and 207.1 ± 5.44 nm, good homogeneity and high zeta-potential values of -26.4 and -32.7 mV were selected as the optimized emulgel. Nanoemulgels were nonirritating of pH value 5.56, readily spreadable, and were physically stable following 10 heating-cooling cycles. Treatment with nanoemulgels showed a two-fold decrease in duration of skin healing and no spongiosis compared to chamomile oil. Levels of biomarkers were reduced after topical application of both nanoemulgels and chamomile oil.: Nanoemulgels are a potential cost effective, safe topical carrier system for chamomile in treating atopic dermatitis.